Clearlife Extra Strength Tablet
NDC Package 62795-1050-2
Package Information
Clearlife Extra Strength (onion, ambrosia artemisiifolia whole, apis mellifera, arnica montana whole, euphrasia stricta, graphite, galphimia glauca flowering top, pulsatilla vulgaris whole, histamine dihydrochloride, pine tar, schoenocaulon officinale seed, sulfur, sulfuric acid, tellurium and thuja occidentalis leafy twig) tablets is for the temporary relief of minor allergy symptoms:Sinus Pressure, runny or itchy nose, Nasal congestion,Allergic Rhinitis, Sneezing, itchy or watery eyes, Allergy related headache, Itchy throat and skin. This formulation utilizes a tablet delivery system. Marketed by Medinatura Inc., this product is identified by NDC 62795-1050.
Identification & Billing
Clinical Specifications
- AMBROSIA ARTEMISIIFOLIA WHOLE 3 [hp_X]/1
- APIS MELLIFERA 4 [hp_X]/1
- ARNICA MONTANA 5 [hp_X]/1
- EUPHRASIA STRICTA 3 [hp_X]/1
- GALPHIMIA GLAUCA FLOWERING TOP 3 [hp_X]/1
- GRAPHITE 10 [hp_X]/1
- HISTAMINE DIHYDROCHLORIDE 8 [hp_X]/1
- ONION 3 [hp_X]/1
- PINE TAR 10 [hp_X]/1
- PULSATILLA VULGARIS WHOLE 4 [hp_X]/1
- SCHOENOCAULON OFFICINALE SEED 6 [hp_X]/1
- SULFUR 4 [hp_X]/1
- SULFURIC ACID 20 [hp_X]/1
- TELLURIUM 10 [hp_X]/1
- THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/1
- Allergens - [CS]
- Allergens - [CS]
- Bee Venoms - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Standardized Insect Venom Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 62795 - Medinatura Inc.
- 62795-1050 - Clearlife Extra Strength
- 62795-1050-2 - 1 BOTTLE in 1 CARTON / 60 TABLET in 1 BOTTLE
- 62795-1050 - Clearlife Extra Strength
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62795-1050-2 identifies a specific commercial package of 1 bottle in 1 carton / 60 tablet in 1 bottle of Clearlife Extra Strength, a human over the counter drug labeled by Medinatura Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet is formulated for oral use and contains ambrosia artemisiifolia whole; apis mellifera; arnica montana; euphrasia stricta; galphimia glauca flowering top; graphite; histamine dihydrochloride; onion; pine tar; pulsatilla vulgaris whole; schoenocaulon officinale seed; sulfur; sulfuric acid; tellurium; thuja occidentalis leafy twig as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medinatura Inc. on January 06, 2021. The current certification is valid through December 31, 2026.
How is this Medinatura Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62795105002. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.